Dobutamine Hydrochloride in Dextrose (Baxter Healthcare Corporation)


Welcome to the PulseAid listing for the Dobutamine Hydrochloride in Dextrose drug offered from Baxter Healthcare Corporation. This Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Baxter Healthcare Corporation
NON-PROPRIETARY NAME: Dobutamine Hydrochloride
SUBSTANCE NAME: DOBUTAMINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1993-09-27
END MARKETING DATE: 0000-00-00


Dobutamine Hydrochloride in Dextrose HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDobutamine Hydrochloride in Dextrose from Baxter Healthcare Corporation
LABELER NAME: Baxter Healthcare Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/100mL)
START MARKETING DATE: 1993-09-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0338-1073_9b33db96-6e6e-4e15-9217-337c1202a885
PRODUCT NDC: 0338-1073
APPLICATION NUMBER: NDA020255

Other DOBUTAMINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxter Healthcare CorporationDobutamine Hydrochloride in Dextrose
General Injectables and Vaccines, Inc.Dobutamine
Hospira, Inc.DOBUTamine Hydrochloride in Dextrose
Physicians Total Care, Inc.Dobutamine